D-1104-2023 Class II Ongoing
FDA drug recall D-1104-2023 was initiated by Inmar Supply Chain Solutions, LLC on August 14, 2023 and is designated Class II. Reason for recall: CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center. Also, due to unusually hot weather, FDA Recalled Products may have been subjected to temperatures in exce… The recall status is ongoing. Affected quantity: Unknown.
Recall Details
- Product Type
- Drugs
- Report Date
- August 30, 2023
- Initiation Date
- August 14, 2023
- Termination Date
- N/A
- Voluntary/Mandated
- N/A
- Product Quantity
- Unknown
Product Description
All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar.
Reason for Recall
CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center. Also, due to unusually hot weather, FDA Recalled Products may have been subjected to temperatures in excess of storage condition instructions on product labeling.
Distribution Pattern
Separate Distribution List (salvage buyers) provided by Inmar and will be uploaded. Final customer distribution unknown.
Code Information
Miscellaneous